Biotechnology startup CrisprBits has raised $250,000 in a pre-seed round led by US-based VJ Group.
The intricate relationship between sleep disturbances,
Xanax Overnight slow-wave sleep, and cognitive functions emphasizes the importance
Lorazepam For Sale Online of recognizing and addressing these issues. This approach may
Xanax No Rx lead to more judicious use of medications, prioritizing non-pharmacologic interventions where appropriate. It has been shown to increase the production of gastric acid and enhance gut motility, which can help
Tramadol Without A Prescription alleviate constipation symptoms. These conditions often create an additional layer of complexity, requiring a careful and individualized approach to treatment. In the US, we
Trusted site to Buy Clonazepam often hear the term "polypharmacy" used to describe patients who take multiple medications. Primary care providers are beginning to integrate discussions
Zolpidem Without A Prescription about sleep into routine check-ups, recognizing that sleep health is as
Zopiclone Overnight Delivery important as managing diet or exercise. As healthcare providers
Buy Ambien Online Without Prescription continue to develop their skills in communication and emotional engagement, patients will likely experience more positive outcomes and a greater sense of
Xanax Legally control over their health journeys. Withdrawal symptoms can be distressing, and for
Ambien Without A Prescription some, the fear of returning to their original state of anxiety may lead them to continue relying on sedatives rather than
Xanax Overnight Shipping exploring other coping strategies. As healthcare practitioners move forward, fostering open communication with patients
Order Xanax No Prescription about their pain experiences and treatment expectations becomes vital.
The proceeds will be deployed towards product development, team expansion and for research and development, CrisprBits said in a press release.
Founded in 2020 by Vijay Chandru, Sunil Arora, Dr. Rajeev Kohli, Bharat Jobanputra, and Aditya Sarda, CrisprBits develops high-quality healthcare solutions in diagnostics and gene editing that all Indians can afford. The company plans to extend its CRISPR-based diagnostics platform to point-of-care detection of pathogens and antimicrobial resistance genes associated with hospital-acquired infections. CRISPR is used by bacteria to protect themselves from invading viruses and in the past few years, scientists have harnessed the power of CRISPR to develop therapeutics as well as other biotechnological products in the domains of human, plant and microbial bio-engineering.
The Delhi and Bengaluru-based startup says it operates under three key principles: using deep science to deliver high quality products, adhering to the highest ethical standards, including in the choice of products they offer, and developing an organisation that draws exceptional individuals with diverse backgrounds and affinities. It also claims to have a laboratory in C-CAMP, a premier incubator for biotechnology innovation in Bengaluru.
According to CrisprBits, it has developed OmniCrisp, a CRISPR-based test to detect SARS-CoV2 and to determine whether it is an Omicron or non-omicron variant. It competes with the likes of Biocon, Sea6 Energy, MedGenome, Bharat Biotech, GANIT Labs, and Forus Health.
Source @Entrackr
